Compare OPK & BYRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OPK | BYRN |
|---|---|---|
| Founded | 2007 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 416.1M |
| IPO Year | 1995 | N/A |
| Metric | OPK | BYRN |
|---|---|---|
| Price | $1.38 | $18.71 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | $2.28 | ★ $41.50 |
| AVG Volume (30 Days) | ★ 2.8M | 292.2K |
| Earning Date | 10-29-2025 | 10-09-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 543.53 |
| EPS | N/A | ★ 0.66 |
| Revenue | ★ $642,067,000.00 | $110,853,000.00 |
| Revenue This Year | N/A | $39.65 |
| Revenue Next Year | N/A | $20.62 |
| P/E Ratio | ★ N/A | $28.39 |
| Revenue Growth | N/A | ★ 50.99 |
| 52 Week Low | $1.11 | $13.68 |
| 52 Week High | $2.04 | $34.78 |
| Indicator | OPK | BYRN |
|---|---|---|
| Relative Strength Index (RSI) | 52.93 | 50.16 |
| Support Level | $1.28 | $18.34 |
| Resistance Level | $1.35 | $19.50 |
| Average True Range (ATR) | 0.05 | 0.78 |
| MACD | 0.01 | 0.23 |
| Stochastic Oscillator | 68.30 | 48.92 |
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
Byrna Technologies Inc is a designer, manufacturer, retailer, and distributor of technological solutions for security situations that do not require the use of lethal force. The company generates its revenue from the United States, South Africa, Europe, South America, Asia, and Canada.